Cost-effectiveness of emission-reducing measures for methane in the Netherlands

被引:2
|
作者
DeJager, D
Blok, K
机构
[1] ECOFYS Research and Consultancy, NL-3503 RK Utrecht
关键词
D O I
10.1016/0196-8904(95)00317-7
中图分类号
O414.1 [热力学];
学科分类号
摘要
The present methane emissions in the Netherlands amount to 1190 ktonne per year. It is expected that these emissions will decrease by 20% up to the year 2000 due to environmental policies already in place. However, additional emission reduction may be necessary. In this article, the reduction potential and specific costs of additional methane emission reduction measures are presented. The most cost-effective options are landfill gas recovery and utilisation, increased gas utilisation on offshore natural gas production platforms and large-scale digestion of animal manure. Other, less cost-effective options are composting, fermentation and incineration of wastes otherwise landfilled, replacement of the grey cast-iron network in the natural gas distribution grid, and a doubling of the leak control frequency. It is found that these measures would result in an extra emission reduction of about 310 ktonne CH4/yr, of which about 160 ktonne CH4/yr could be avoided with negative or zero net costs. With respect to the 1990 emissions, this would mean a reduction of about 45% and 30% respectively.
引用
收藏
页码:1181 / 1186
页数:6
相关论文
共 50 条
  • [41] Cost-effectiveness of mass vaccination with a rotavirus vaccine in the Netherlands
    Al, M. J.
    Goossens, L.
    Hovels, A. M.
    Michielsen, C. P.
    Standaert, B. A.
    VALUE IN HEALTH, 2006, 9 (06) : A304 - A304
  • [42] Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands
    Blommestein, Hedwig M.
    de Groot, Saskia
    Aarts, Mieke J.
    Vemer, Pepijn
    de Vries, Robin
    van Abeelen, Annet F. M.
    Posthuma, E. F. M. Ward
    Uyl-de Groota, Carin A.
    LEUKEMIA RESEARCH, 2016, 50 : 37 - 45
  • [43] Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands
    Postma, MJ
    van Hulst, M
    De Wolf, JTM
    Botteman, M
    Staginnus, U
    TRANSFUSION MEDICINE, 2005, 15 (05) : 379 - 387
  • [44] COST-EFFECTIVENESS OF RITUXIMAB IN THE TREATMENT OF RA PATIENTS IN THE NETHERLANDS
    Diamantopoulos, A.
    Kievit, W.
    De Vries, R.
    Pompen, M.
    VALUE IN HEALTH, 2011, 14 (07) : A311 - A311
  • [45] The cost-effectiveness of hearing-aid fitting in the Netherlands
    Joore, MA
    van der Stel, H
    Peters, HJM
    Boas, GM
    Anteunis, JC
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (03) : 297 - 304
  • [46] Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands
    Lenoir-Wijnkoop, I.
    van Aalderen, W. M. C.
    Boehm, G.
    Klaassen, D.
    Sprikkelman, A. B.
    Nuijten, M. J. C.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (01): : 101 - 110
  • [47] COST-EFFECTIVENESS OF CLADRIBINE TABLETS FOR TREATMENT OF RRMS IN THE NETHERLANDS
    de Francesco, M.
    Mahajan, K.
    Michels, R. E.
    Schiffers, K.
    Budhia, S.
    Harty, G.
    Krol, M.
    VALUE IN HEALTH, 2018, 21 : S339 - S340
  • [48] Re: Cost-effectiveness of pertussis booster vaccination in the Netherlands
    O'Mahony, James F.
    VACCINE, 2012, 30 (50) : 7141 - 7141
  • [49] Cost-effectiveness measures on convex and nonconvex technologies
    Fukuyama, Hirofumi
    Shiraz, Rashed Khanjani
    EUROPEAN JOURNAL OF OPERATIONAL RESEARCH, 2015, 246 (01) : 307 - 319
  • [50] COST-EFFECTIVENESS OF MEASURES FOR CONTROL OF DIARRHEAL DISEASES
    不详
    LANCET, 1987, 2 (8553): : 289 - 289